Netherlands-based GenScript Biotech said that its SARS-CoV-2 diagnostic products have received the CE Mark for IVD tests (CE-IVD).
These products include the company's cPass SARS-CoV-2 Surrogate Virus Neutralization test (sVNT) kit, which the company says detects the presence of antibodies in an hour and doesn't require live biological materials or biosafety containment for testing. The kit was developed from an exclusive partnership between Dr. Linfa Wang at Duke National University of Singapore (Duke-NUS) Medical School, GenScript, and Singapore's Agency for Science Technology and Research.
In a statement from GenScript, Wang said that the test kit can be used for contact tracing, reservoir or intermediate animal tracking, as well as for assessment of herd immunity, the longevity of protective immunity, and the efficacy of different vaccine candidates.GenScript also offers quantitative reverse transcription polymerase chain reaction (RT-PCR) detection kits, as well as immunoglobulin G (IgG) and immunoglobulin M (IgM) serological testing kits.
